The pharmaceuticals industry makes a major contribution to the economy hosting hundreds of enterprises, including two of the world’s biggest: AstraZeneca and GlaxoSmithKline.
While the industry has historically been slower than many to adopt emerging technologies, this is rapidly changing. There’s just one problem: this digital transformation is exposing pharma firms to a greater risk of data theft, operational disruption and non-compliance.
The bulk of the risk stems from threats that misuse the DNS, so this is where organisations must focus their efforts.
This tip sheet highlights the actions IT and security teams can take.